KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EBIT (2018 - 2025)

Historic EBIT for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$32.9 million.

  • Twist Bioscience's EBIT rose 503.41% to -$32.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$134.5 million, marking a year-over-year increase of 3548.43%. This contributed to the annual value of -$136.3 million for FY2025, which is 3829.72% up from last year.
  • Twist Bioscience's EBIT amounted to -$32.9 million in Q4 2025, which was up 503.41% from -$29.9 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's EBIT ranged from a high of -$29.9 million in Q3 2025 and a low of -$88.9 million during Q2 2024
  • Moreover, its 5-year median value for EBIT was -$45.8 million (2022), whereas its average is -$48.1 million.
  • Per our database at Business Quant, Twist Bioscience's EBIT crashed by 7058.52% in 2021 and then skyrocketed by 6612.76% in 2025.
  • Over the past 5 years, Twist Bioscience's EBIT (Quarter) stood at -$55.9 million in 2021, then grew by 20.22% to -$44.6 million in 2022, then decreased by 5.26% to -$47.0 million in 2023, then grew by 26.25% to -$34.6 million in 2024, then rose by 5.03% to -$32.9 million in 2025.
  • Its EBIT stands at -$32.9 million for Q4 2025, versus -$29.9 million for Q3 2025 and -$30.1 million for Q2 2025.